Literature DB >> 2184194

Macro enzymes: prevalence, composition, detection and clinical relevance.

A Sturk1, G T Sanders.   

Abstract

The presence of a macro enzyme, i.e. an enzyme with an abnormally high molecular weight, frequently leads to a genuinely increased serum activity or an interference in laboratory assays. This may thereby result in false positive diagnoses, such as acute myocardial infarction or pancreatitis. The various forms of macro enzymes are reviewed. In the case of immune complexes the immunoglobulins and (iso)-enzymes involved are discussed, as well as the specificity of the interaction, the prevalence and clinical relevance, associations with autoimmune or other diseases, and their behaviour in laboratory assays.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184194

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  4 in total

1.  Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference.

Authors: 
Journal:  Clin Biochem Rev       Date:  2004

2.  Isolated aspartate aminotransferase elevation: think macro-AST.

Authors:  Maximilian Lee; Pietro Vajro; Emmet B Keeffe
Journal:  Dig Dis Sci       Date:  2011-01-19       Impact factor: 3.199

3.  Clinical role of recurrently elevated macro creatine kinase type 1.

Authors:  Ju-Feng Hsiao; Hsiao-Chen Ning; Po-Wen Gu; Wei-Yee Lin; Pao-Hsien Chu
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

4.  Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.

Authors:  Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Claudia Battista; Alessandro Bozzao; Marco Caputo; Enrica Ciccarelli; Laura De Marinis; Ernesto De Menis; Marco Faustini Fustini; Franco Grimaldi; Andrea Lania; Giovanni Lasio; Francesco Logoluso; Marco Losa; Pietro Maffei; Davide Milani; Maurizio Poggi; Michele Zini; Laurence Katznelson; Anton Luger; Catalina Poiana
Journal:  Eur J Endocrinol       Date:  2022-02-03       Impact factor: 6.664

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.